8-苯氧基辛基溴化物 | 52176-61-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 8-苯氧基辛基溴化物
• 英文名称: 1-(8-bromooctyloxy)benzene
• 英文别名: (8-bromooctyloxy)benzene；1-bromo-8-phenoxyoctane；8-bromo-phenoxyoctane；(8-bromo-octyl)-phenyl ether；(8-Brom-octyl)-phenyl-aether；8-Brom-1-phenoxy-octan；8-Phenoxyoctyl bromide；8-bromooctoxybenzene
• CAS: 52176-61-1
• 化学式: C₁₄H₂₁BrO
• 分子量: 285.224
• InChiKey: GSSAJHSMHLLHDC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  16
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2909309090

反应信息

• 作为反应物：
  描述：

  8-苯氧基辛基溴化物 以 甲醇 为溶剂， 反应 44.0h， 生成
  参考文献：
  名称：

  1-Phenoxyalkyl-4-[(N,N-disubstitutedamino)alkyl]piperazine derivatives as non-imidazole histamine H3-antagonists

  摘要：

  In this study, a series of 1-phenoxyalkyl-4-[(N,N-disubstitutedamino)alkyl]piperazine derivatives has been prepared and in vitro tested as H-3-receptor antagonists (electrically evoked contraction of the guinea pig jejunum). All compounds investigated show moderate in vitro affinities. The most potent antagonists in this series are the compounds 9b, 1b, 1f, and 1l, which exhibit, independently of the substituent at the end of -N- moiety, almost the same level of affinity (pA (2) = 7.18, pA (2) = 7.27, pA (2) = 7.13, pA (2) = 7.12, respectively). The histaminergic H-1 antagonism of the aforementioned four products was established on the isolated guinea pig ileum by conventional methods; the pA (2) values were compared with the potency of pyrilamine. None of them shows any H-1-antagonistic activity (pA (2) < 4; for pyrilamine pA (2) = 9.35).

  DOI：

  10.1007/s00044-012-0090-2
• 作为产物：
  描述：

  1,8-二溴辛烷 在 sodium phenoxide 作用下， 以75%的产率得到8-苯氧基辛基溴化物
  参考文献：
  名称：

  Aminodesoxy-1.4;3.6-dianhydrohexitol nitrates and pharmaceutical

  摘要：

  一般式I的氨基去氧-1.4;3.6-二羟基环己醇硝酸酯，其中R.sup.1和R.sup.2具有权利要求1中给出的含义，以及它们的药理学上可接受的酸盐；制备上述化合物的方法，以及含有至少一种上述化合物的药物组合物。

  公开号：

  US04363805A1

文献信息

• Zwitterionic Sulfobetaine Inhibitors of Squalene Synthase
  作者：Thomas A. Spencer、Thomas J. Onofrey、Reginald O. Cann、Jonathon S. Russel、Laura E. Lee、Daniel E. Blanchard、Alfredo Castro、Peide Gu、Guojian Jiang、Ishaiahu Shechter

  DOI：10.1021/jo981617q

  日期：1999.2.1

  A substantial number of sulfobetaines (e.g., 10) have been synthesized and evaluated as inhibitors of squalene synthase (SS) on the basis of the idea that their zwitterionic structure would have properties conducive both to binding in the active site and to passage through cell membranes. When the simple sulfobetaine moiety is incorporated into compounds containing hydrophobic portions like those in

  已经合成了大量的磺基甜菜碱（例如10种），并根据其两性离子结构具有有助于在活性位点结合和通过细胞膜通过的特性，被认为是鲨烯合酶（SS）的抑制剂。 。当将简单的磺基甜菜碱部分掺入含有疏水部分的化合物中时，如法呢基二磷酸酯（1）或角鲨烯二磷酸酯（2）中的那些，确实在大鼠肝微粒体测定中观察到了SS的抑制作用。例如，法呢基化磺基甜菜碱10具有抑制SS的IC（50）＝10μM，而芳香族衍生物35具有IC（50）＝2μM。研究了多种结构修饰，例如化合物43、52、76、85、91、99、111和115。不幸，
• Modifications of primaquine as antimalarials. 4. 5-Alkoxy derivatives of primaquine
  作者：Eugene H. Chen、Keiichi Tanabe、Andrew J. Saggiomo、Edward A. Nodiff

  DOI：10.1021/jm00390a012

  日期：1987.7

  blood schizonticides (Plasmodium berghei, mouse) and tissue schizonticides (Plasmodium cynomolgi, monkey). Several of these compounds were extremely active in both screens. Such a broad spectrum of antimalarial efficacy offers the possibility of a single drug that could cure the various relapsing and nonrelapsing malarias.

  已经合成了三十二个5-烷氧基伯氨喹，并被评估为血型裂殖剂（伯氏疟原虫，小鼠）和组织型裂殖剂（食蟹毛疟原虫，猴子）。这些化合物中的几种在两种筛选中均具有极高的活性。如此广泛的抗疟疾功效提供了一种可以治愈各种复发性和非复发性疟疾的药物。
• Synthesis and pharmacological assessment of diversely substituted pyrazolo[3,4-b]quinoline, and benzo[b]pyrazolo[4,3-g][1,8]naphthyridine derivatives
  作者：Daniel Silva、Mourad Chioua、Abdelouahid Samadi、M. Carmo Carreiras、María-Luisa Jimeno、Eduarda Mendes、Cristóbal de los Ríos、Alejandro Romero、Mercedes Villarroya、Manuela G. López、José Marco-Contelles

  DOI：10.1016/j.ejmech.2011.05.068

  日期：2011.9

  The synthesis and pharmacological analyses of a number of pyrazolo[3,4-b]quinoline and benzo[b]pyrazolo[4,3-g][1,8]naphthyridine derivatives are reported. We have synthesized the diversely substituted tacrine analogues 1–6, by Friedländer-type reaction of readily available o-amino-1-methyl-pyrazole-dicarbonitriles with cyclohexanone. The biological evaluation showed that pyrazolotacrines 1–6 are inhibitors

  报道了许多吡唑并[3,4- b ]喹啉和苯并[ b ]吡唑并[4,3- g ] [1,8]萘啶衍生物的合成和药理学分析。我们已合成了不同地取代的他克林的类似物1 - 6，由易得的德兰德型反应ø -氨基-1-甲基-吡唑烷二腈与环己酮。生物学评估表明，吡唑并ac碱1 – 6是电的乙酰胆碱酯酶（E的抑制剂）。eAChE），在微摩尔范围内，对血清马丁酰胆碱酯酶（eqBuChE）的抑制作用具有很高的选择性；最有趣的抑制剂是N-（5-氨基-1-甲基-6,7,8,9-四氢-1 H-苯并[ b ]吡唑并[4,3- g ] [1,8]萘啶-3-酰基）乙酰胺（5）[IC 50（E eAChE）= 0.069±0.006μM; IC 50（eqBuChE）= 6.3±0.6μM]。动力学研究表明，化合物5是E eAChE的混合型抑制剂（K i  = 155 nM）。抑制剂5对鱼藤酮/寡霉素A诱导的神经元死亡显示出45％的神经保护值。
• Encapsulating propeller-like columnar liquid crystals with an aromatic outer shell: influence of phenoxy-terminated side chains on the phase behaviour of triphenylbenzenes
  作者：Korinna Bader、Tobias Wöhrle、Esra Öztürk、Angelika Baro、Sabine Laschat

  DOI：10.1039/c8sm00590g

  日期：——

  temperatures of columnar liquid crystals by side chain variation is often associated with an undesired change in the mesophase type and/or geometry. To overcome this problem phenoxy-terminated side chains rather than alkyl side chains were grafted onto triphenylbenzenes, which resulted in reduced clearing points, while melting points were little affected. More importantly, helical columnar self-assembly was not

  通过侧链变化来调节柱状液晶的相变温度通常与中间相类型和/或几何形状的不期望的变化有关。为了克服这个问题，将苯氧基封端的侧链而不是烷基侧链接枝到三苯苯上，这导致清除点降低，而熔点几乎不受影响。更重要的是，螺旋圆柱状的自组装没有受到损害。
• Phosphonate-Functionalized Donor Polymer as an Underlying Interlayer To Improve Active Layer Morphology in Polymer Solar Cells
  作者：Bin Meng、Yingying Fu、Zhiyuan Xie、Jun Liu、Lixiang Wang

  DOI：10.1021/ma5008754

  日期：2014.9.23

  novel polymer is developed and used as underlying interlayer to improve donor polymer/acceptor material blend morphology of active layer in polymer solar cells (PSCs). The polymer polyN-9-[1,17-bis(diethylphosphonate)heptadecanyl]-2,7-carbazole-alt-5,5-(4,7-di-2-thienyl-2,1,3-benzothiadiazole)} (PCDTBT-Pho) is designed by attaching polar phosphonate moieties to the side chain of the donor polymer, p

  开发了一种新型聚合物并将其用作基础中间层，以改善聚合物太阳能电池（PSC）中活性层的供体聚合物/受体材料混合形态。聚合物聚 Ñ -9- [1,17双（膦酸二乙酯）heptadecanyl] -2,7-咔唑ALT -5,5-（4,7-二-2-噻吩基-2,1,3-苯并噻二唑）}（PCDTBT-PHO）由极性膦酸酯部分附接至所述供体聚合物的侧链，聚[设计ñ -9- heptadecanyl -2,7-咔唑中高音-5，5-（4，7-二-2-噻吩基-2，1，3-苯并噻二唑）]（PCDTBT）。膦酸酯侧基导致PCDTBT-Pho的不同溶解度和适当的表面能。结果，在PSC器件中，下面的PCDTBT-Pho层有助于在活性层中形成双连续网络形态，使供体聚合物在阳极侧富集，并促使供体聚合物结晶。这些改进有助于改善电荷的分离和传输，从而使PSC器件的短路电流密度提高了12％，功率转换效率提高了8％。因此，PC